Oragenics (OGEN) Change in Cash (2010 - 2026)
Oragenics' (OGEN) quarterly Change in Cash came in at $1.7 million in Q1 2026, down 33.21% YoY from $2.6 million in Q1 2025, and up 156.84% on a QoQ basis from -$3.0 million in Q4 2025.
Oragenics (OGEN) Change in Cash (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 17 years of Change in Cash data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Change in Cash fell 33.21% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 395.59% YoY) and the FY2025 annual result came in at $7.5 million, up 387.74% from the prior year.
- Change in Cash rose to $1.7 million in Q1 2026, from -$3.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $9.4 million in Q3 2025 to a low of -$5.9 million in Q1 2022.
- A 5-year average of -$1.0 million and a median of -$2.3 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash sank 131.25% — and 2025, when it surged 425.22%.
- Tracing OGEN's Change in Cash over 5 years: stood at -$2.5 million in 2022, then grew by 9.55% to -$2.3 million in 2023, then rose by 0.17% to -$2.3 million in 2024, then tumbled by 31.8% to -$3.0 million in 2025, then soared by 156.84% to $1.7 million in 2026.
- The last three Change in Cash figures came in at $1.7 million (Q1 2026), -$3.0 million (Q4 2025), and $9.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | -2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.24 Mn |
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Sep 30, 2025 | 9.43 Mn |
| Jun 30, 2025 | -1.45 Mn |
| Mar 31, 2025 | 2.56 Mn |
| Dec 31, 2024 | -2.28 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | -723,368.00 |
| Mar 31, 2024 | -1.41 Mn |
| Dec 31, 2023 | -2.28 Mn |
| Sep 30, 2023 | -707,178.00 |
| Jun 30, 2023 | -2.68 Mn |
| Mar 31, 2023 | -2.27 Mn |
| Dec 31, 2022 | -2.52 Mn |
| Sep 30, 2022 | -3.92 Mn |
| Jun 30, 2022 | -3.50 Mn |
| Mar 31, 2022 | -5.89 Mn |
| Dec 31, 2021 | -2.68 Mn |
| Sep 30, 2021 | -4.63 Mn |